Genomma Lab Internacional, S.A.B. de C.V. Share Price
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Mexican S.E.
31/08/2026
|
5-day change | 1st Jan Change | ||
| 13.20 MXN | -2.22% |
|
-2.80% | -26.22% |
| Market Cap | 1.29TCr 76Cr 65Cr 62Cr 56Cr 105.48Cr 7.2TCr 106.05Cr 727.88Cr 283.31Cr 3.66TCr 284.9Cr 278.72Cr 12TCr | P/E 2026 * |
5.16x | P/E 2027 * | 6.19x |
|---|---|---|---|---|---|
| Enterprise Value | 1.73TCr 102.14Cr 88Cr 83Cr 75Cr 141.97Cr 9.69TCr 142.74Cr 979.72Cr 381.33Cr 4.93TCr 383.47Cr 375.15Cr 16TCr | EV / Sales 2026 * |
0.93x | EV / Sales 2027 * | 0.86x |
| Free-Float |
68.95% | Yield 2026 * |
6.32% | Yield 2027 * | 9.33% |
Last Transcript : Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | -2.22% | ||
| 1 week | -2.80% | ||
| 1 month | -10.08% | ||
| 3 months | -17.40% | ||
| 6 months | -27.59% | ||
| Current year | -26.22% |
| 1 week | 13.12 |  | 13.74 |
| 1 month | 13.12 | | 14.92 |
| Current year | 13.12 | | 19.48 |
| 1 year | 13.12 | | 23.2 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 12/04/2023 |
| Director of Finance/CFO | - | 01/12/2015 | |
| Investor Relations Contact | - | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/10/1996 | |
Juan Alonso
BRD | Director/Board Member | - | 06/07/2010 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.22% | -2.80% | -40.99% | -4.56% | 76Cr | |
| +0.28% | -5.98% | +57.77% | +108.21% | 1,03100Cr | |
| +2.01% | -0.71% | +52.30% | +68.99% | 64TCr | |
| +1.39% | -2.16% | +22.71% | +75.47% | 45TCr | |
| -1.50% | -6.18% | +33.50% | +33.50% | 35TCr | |
| +6.25% | +3.31% | +29.46% | +46.64% | 29TCr | |
| -0.07% | -1.22% | +1.46% | +12.19% | 25TCr | |
| +1.92% | -0.93% | +52.70% | +70.67% | 23TCr | |
| +0.51% | -1.79% | -18.09% | -53.86% | 20TCr | |
| +2.45% | +0.77% | +33.01% | +95.59% | 18TCr | |
| Average | +0.74% | -2.89% | +22.38% | +45.28% | 36.31TCr | |
| Weighted average by Cap. | +0.94% | -3.97% | +38.16% | +66.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.87TCr 110.39Cr 95Cr 90Cr 82Cr 153.45Cr 10TCr 154.28Cr 1.06TCr 412.16Cr 5.33TCr 414.47Cr 405.48Cr 18TCr | 1.92TCr 113.15Cr 98Cr 92Cr 84Cr 157.29Cr 11TCr 158.14Cr 1.09TCr 422.47Cr 5.46TCr 424.83Cr 415.62Cr 18TCr |
| Net income | 219.4Cr 13Cr 11Cr 10Cr 9.56Cr 18Cr 1.23TCr 18Cr 124.08Cr 48Cr 624.48Cr 49Cr 48Cr 2.07TCr | 217.71Cr 13Cr 11Cr 10Cr 9.49Cr 18Cr 1.22TCr 18Cr 123.13Cr 48Cr 619.67Cr 48Cr 47Cr 2.05TCr |
| Net Debt | 445.3Cr 26Cr 23Cr 21Cr 19Cr 36Cr 2.49TCr 37Cr 251.84Cr 98Cr 1.27TCr 99Cr 96Cr 4.2TCr | 355.89Cr 21Cr 18Cr 17Cr 16Cr 29Cr 1.99TCr 29Cr 201.27Cr 78Cr 1.01TCr 79Cr 77Cr 3.36TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | MX$13.20 | -2.22% | 54,86,178 |
| 28/26/28 | MX$13.50 | -0.07% | 25,10,850 |
| 27/26/27 | MX$13.51 | -.--% | 30,97,748 |
| 26/26/26 | MX$13.51 | +0.22% | 33,58,134 |
| 25/26/25 | MX$13.48 | -0.74% | 23,66,021 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Select your edition
All financial news and data tailored to specific country editions
